OSA Is Risk Factor for Recurrent Pulmonary Embolism

OSA Is Risk Factor for Recurrent Pulmonary Embolism
Share on FacebookTweet about this on TwitterShare on LinkedIn

TUESDAY, Dec. 13, 2016 (HealthDay News) — For patients who stop oral anticoagulation (OAC) for a first episode of pulmonary embolism (PE), obstructive sleep apnea (OSA) is a risk factor for PE recurrence and restarting OAC for a new thromboembolic event, according to a study published in the December issue of CHEST.

Alberto Alonso-Fernández, M.D., Ph.D., from the University Hospital Son Espases in Palma de Mallorca, Spain, and colleagues examined the prognostic value of OSA after discontinuation of OAC in 120 patients with a first episode of PE. Patients were followed for five to eight years for a primary end point of PE recurrence.

The researchers found that 19 patients had a PE recurrence during the follow-up period, and 16 of the patients had an apnea-hypopnea index (AHI) ≥10 h−1. Independent risk factors for recurrent PE included AHI ≥10 h−1, mean nocturnal oxygen saturation (nSaO2), time with SaO2 <90 percent, and D-dimer level (hazard ratios, 20.73, 0.39, 0.90, and 1.001, respectively). Twenty-four patients resumed OAC for any thromboembolic event; independent risk factors for the resumption of OAC included AHI ≥10 h−1, nSaO2, and Epworth Sleepiness Scale (hazard ratios, 20.66, 0.54, and 0.73, respectively).

“After a first episode of PE, OSA is an independent risk factor for PE recurrence or restarting OAC for a new thromboembolic event,” the authors write.

Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Submit a Comment

Your email address will not be published. Required fields are marked *

twelve − four =